Partner | 全球健康药物研发中心

Our Partners

FOUNDING PARTNERS

Bill & Melinda Gates Foundation

Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people's health and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to ensure that all people—especially those with the fewest resources—have access to the opportunities they need to succeed in school and life.

Based in Seattle, Washington, the foundation is led by CEO Mark Suzman and Co-chair William H. Gates Sr., under the direction of Bill and Melinda Gates and Warren Buffett. It provides GHDDI with generous initiation and research funding as well as assistance on institutional development.

http://www.gatesfoundation.org/

Tsinghua University

Established in 1911, Tsinghua University is widely acknowledged and consistently ranked as the top academic and research institution in China, while also enjoying a global reputation. It has a strong foundation in biomedical research, including life sciences, basic medical sciences, biomedical engineering, chemistry and information technology.

The School of Pharmaceutical Sciences (SPS) is Tsinghua’s correspondent collaborator for GHDDI, providing various resources to support the development of the Institute, such as research collaboration, talent recruitment, and operation management.

http://www.tsinghua.edu.cn/ http://www.sps.tsinghua.edu.cn/

Beijing Municipal Science and Technology Commission

Beijing Municipal Government has been actively promoting pharmaceutical innovations in small molecule drug, Chinese traditional medicine, biologics and medical device by providing significant financial, regulatory and talent development support. Through an innovative Public-Private Partnership (PPP) model, Beijing Municipal Science and Technology Commission supports GHDDI with grants and policy innovations, which is also facilitated by Beijing Municipal Bureau of Finance, Beijing Municipal Bureau of Civil Affairs, Haidian District Government and Dongsheng Township Government.

http://kw.beijing.gov.cn/

STRATEGIC AND TECHNOLOGICAL PARTNER

California Institute for Biomedical Research (Calibr)

Calibr is an independent not-for-profit institute established in 2012 focusing on translational medicine. It has demonstrated an effective early drug development model through collaborations with researchers across the world while enabling commercial partnerships to bring new candidate therapeutics to the public. Value created from these activities is reinvested in preclinical and clinical research at the institute to create a self-sustaining, ‘evergreen’ model for not-for-profit biomedical research.

Calibr has demonstrated a model of early drug discovery for GHDDI. The Institute also led the effort of acquiring the ReFRAME compound library and provided advice on project portfolios. We have initiated multiple collaboration projects with Calibr.

http://www.calibr.org/